Key terms
About BMRN
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest BMRN news
Apr 15
7:35pm ET
Buy Rating Affirmed for BioMarin Pharmaceutical Amidst Strong Sales Outlook and Optimized Market Expectations
Apr 12
11:25am ET
BioMarin participates in a conference call with JPMorgan.
Apr 12
8:33am ET
Analysts Are Bullish on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN), Regeneron (REGN)
Apr 12
4:55am ET
BioMarin participates in a conference call with JPMorgan.
Apr 11
5:29pm ET
BioMarin participates in a conference call with JPMorgan.
Apr 08
10:40pm ET
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), BioMarin Pharmaceutical (BMRN) and ACADIA Pharmaceuticals (ACAD)
Mar 26
7:10am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Day One Biopharmaceuticals (DAWN), BioMarin Pharmaceutical (BMRN) and Argenx Se (ARGX)
Mar 13
8:25am ET
Buy Rating Justified by Voxzogo’s Efficacy in Hypochondroplasia Treatment: A Deep Dive into BioMarin Pharmaceutical’s Clinical Data
Mar 13
7:11am ET
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Bioventus (BVS) and Pliant Therapeutics (PLRX)
Mar 12
8:36am ET
BioMarin presents new data for Voxzogo in achondroplasia and achondroplasia
Mar 11
3:35pm ET
Fly Insider : Echostar, Dell among week’s notable insider trades
Mar 08
5:39am ET
Wells Fargo Remains a Buy on BioMarin Pharmaceutical (BMRN)
Mar 07
6:58pm ET
BioMarin exec Fuchs sells 35,341 common shares
Mar 07
8:32am ET
BioMarin appoints Cristin Hubbard as Chief Commercial Officer
Mar 07
7:51am ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: BioMarin Pharmaceutical (BMRN) and Andlauer Healthcare Group (OtherANDHF)
Mar 06
7:35am ET
BioMarin Pharmaceutical (BMRN) Gets a Buy from TD Cowen
Mar 01
8:35am ET
Buy Rating Justified by BioMarin’s Strategic R&D and Voxzogo’s Market Potential
Feb 27
1:00am ET
New Share Price & Shareholder Rights Risk for Biomarin Pharmaceutical Inc. – What’s the Latest?
Feb 26
1:45pm ET
BioMarin discloses receipt of subpoena from U.S. Department of Justice
Feb 26
8:06am ET
BioMarin Pharmaceutical (BMRN) Gets a Hold from Oppenheimer
Feb 26
2:16am ET
Buy Rating Affirmed for BioMarin on Strong Sales and Promising Growth Outlook
Feb 26
12:05am ET
Buy Rating for BioMarin on Strong Q4 Performance and Promising Profitability Outlook
Feb 25
11:30pm ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 23
9:05am ET
Maintaining Hold: BioMarin’s Transitional Phase and VOXZOGO’s Growth Potential
Feb 23
8:33am ET
BioMarin price target lowered to $107 from $115 at Piper Sandler
Feb 23
7:51am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Penumbra (PEN), BioMarin Pharmaceutical (BMRN) and Insulet (PODD)
Feb 23
7:31am ET
Analysts Are Bullish on Top Healthcare Stocks: Collegium Pharmaceutical (COLL), Penumbra (PEN)
Feb 23
7:27am ET
Strong Voxzogo Performance Underpins Buy Rating for BioMarin Pharmaceutical
Feb 23
7:21am ET
Scotiabank Reaffirms Their Hold Rating on BioMarin Pharmaceutical (BMRN)
Feb 23
7:21am ET
Stifel Nicolaus Keeps Their Buy Rating on BioMarin Pharmaceutical (BMRN)
Feb 23
7:11am ET
Analysts’ Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Cogent Biosciences (COGT)
No recent press releases are available for BMRN
BMRN Financials
Key terms
Ad Feedback
BMRN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
BMRN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range